Eastward Capital Partners
VC Fund
West Newton, United States
Eastward Capital Partners is a U.S.-based venture debt firm investing in IT, communications, alternative energy, and healthcare companies.
- Total investments:
- 126
- Last investment:
- Lead investor:
- 8%
- Fund size:
- $93M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Eastward Capital Partners invests in
Stages Eastward Capital Partners invests in
Countries Eastward Capital Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 9 contacts → | |||
Round size
- Series A
- $2M–$12M
- Series B
- $5.5M–$30M
- Venture - Series Unknown
- $4.3M–$35M
Investment Focus
Industry
- Software 22 (17%)
- Health Care 20 (16%)
- Information Technology 14 (11%)
- E-Commerce 13 (10%)
- Analytics 12 (10%)
Stage
- Series A 30 (24%)
- Series B 21 (17%)
- Venture - Series Unknown 20 (16%)
- Funding Round 16 (13%)
- Series C 12 (10%)
Country
- United States 113 (90%)
- Canada 3 (2%)
- Ireland 1 (1%)
- Cayman Islands 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Susan M. Nardini
Lease Administrator
|
Lease Administrator | Total investments: 0 | Find email | |
Timothy O'Loughlin
Investment Partner
|
Investment Partner | Total investments: 1 | Find email | |
Christopher Bodnar
Investment Partner
|
Investment Partner | Total investments: 1 | Find email | |
Dennis P. Cameron
Founder and Owner
|
Founder and Owner | Total investments: 0 | Find email | |
Edward I. Dresner
Investment Partner
|
Investment Partner | Total investments: 0 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| HealthSnap is a remote patient monitoring platform for virtual chronic disease management. By making personalized and actionable health data accessible to everyone, HealthSnap empowers people living with chronic conditions anytime, anywhere. The company combines a comprehensive Remote Patient Monitoring Platform with remote care services that makeit simple and profitable for healthcare organizations to improve patient outcomes, reduce readmissions, and lower the cost of care with virtual chronic disease management programs. | $25M / Debt Financing / Aug 06, 2026 | ||
| Lightmatter uses light to create photonic compute chips specialized for AI.Untethered from the limits of Moore’s Law and Dennard Scaling, they’ve rewritten the rules of processor performance scaling by combining electronics, photonics, and new algorithms to create a next-generation computing platform purpose-built for artificial intelligence.Lightmatter is building the engines that will power discoveries, drive progress, and reduce our impact on the planet. | $155M / Series C / Dec 19, 2023 | ||
| GAN Integrity gives compliance teams a better way to do their good work. With a flexible platform that unifies compliance, ethics, and third-party risk management across the enterprise, coupled with deep domain expertise, we make it easy for compliance teams to see everything, adapt to anything, and get all the help they need. That’s why leadingcompanies worldwide — from manufacturing to energy to financial services — rely on GAN Integrity. | Series C / Oct 26, 2023 | ||
| Bigleaf is a cloud-based internet redundancy and optimization service that provides improved reliability, performance, and support, for businesses that rely on the internet. This enables increased protection from business disruption, delivers the full potential of cloud and remote applications, and creates peace of mind for stakeholders.Withpreviously unavailable features such as seamless failover for all applications, circuit-aware load balancing, and true Quality-of-Service over commodity internet, Bigleaf is the evolution of internet connectivity. | $10M / Venture - Series Unknown / Oct 22, 2023 | ||
| Archer Roose is a clean wine brand cultivating a new generation of consumers through a global portfolio and a tech platform making wine more accessible than ever before. | Venture - Series Unknown / Oct 01, 2023 | ||
| Viome is a provider of comprehensive health insights designed to help people track their microbiome health, mitochondrial health, cellular health, and biological age. The company's insights help users to make suitable lifestyle and nutrition choices for them, enabling users to assess their internal eco-system with simple personalizedrecommendations.Viome was established on October 1, 2016 by Naveen Jain in Bellevue, Washington. | $86.5M / Series C / Aug 18, 2023 | ||
| Mixlab is a modern pet pharmacy for veterinarians and pet parents. Our technology and customer experience greatly enhance veterinarian processes and ensure that pet parents receive personalized care that delights them. | $10M / Series A / Aug 14, 2023 | ||
| Simbe Robotics automates repetitive tasks in retail execution. Tally, performs the repetitive and laborious tasks of auditing shelves for out-of-stock items, low stock items, misplaced items, and pricing errors. Tally operates safely during normal store hours alongside shoppers and employees. | $28M / Series B / Jul 13, 2023 | ||
| HOP WTR is a calorie-free sparkling water brewed with hops, adaptogens, and nootropics that is filled with health benefits. | Series A / Jul 01, 2023 | ||
| Cure is a VC-backed hydration brand based in New York City. We’re the only premium hydration brand with a science-backed formula, plant-based ingredients, no added sugar, and 4x the electrolytes of leading sports drinks. The product is based on the World Health Organization's formula for Oral Rehydration Solution that is proven to hydrate aseffectively as an IV drip but, unlike other ORS products, the ingredients are non-GMO, sustainably sourced, and have no added sugar. Made with coconut water and pink Himalayan salt, Cure provides everything your body needs for daily hydration and nothing it doesn't. Cure is backed by a medical advisory board that includes Dr. Roshini Raj, Dr. Dana Cohen, and Brooke Alpert and is FSA/HSA Eligible. In just 4 years, Cure has expanded to over 13,000 retail stores nationwide including CVS, Walgreens, and Sprouts, and was named to the Inc. 5000 list of fastest-growing companies in America at #225 (#10 in Food and Beverage). Cure is a female-founded company, certified Plastic Neutral, and donates a serving for every purchase made to someone in need. Our investors include Lerer Hippeau, Valedor Partners, Rocana Ventures, Beliade, Silas Capital, Litani Ventures, Joyance Partners, Parallel Ventures, Great Oaks Venture Capital, Simple Food Ventures, Carly Strife (Founder of BARK), Kathleen King (Founder of Tate's Cookies), Philip Krim (CEO at Casper), Nick Green (CEO at Thrive Market), Nas, Andy Roddick and more. | $5.6M / Series A / Apr 17, 2023 | ||
| See all 126 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Eastward Capital Partners invest in?
Eastward Capital Partners invests primarily in Software, Health Care and Information Technology startups, most often at Series A and Series B stage. Most of the 126 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Eastward Capital Partners invest in?
Eastward Capital Partners typically joins rounds of $2M–$12M at Series A, $5.5M–$30M at Series B and $4.3M–$35M at Venture - Series Unknown. These are whole funding-round sizes, not Eastward Capital Partners's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Eastward Capital Partners took part in.
How do I contact Eastward Capital Partners?
Public channels for Eastward Capital Partners include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Eastward Capital Partners?
The team at Eastward Capital Partners includes Susan M. Nardini (Lease Administrator), Timothy O'Loughlin (Investment Partner) and Christopher Bodnar (Investment Partner), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
